EMT has been clinically adopted and evolved in human cancers, and the identification of the signaling pathways that lead to activation of the EMT protocols serve as promising therapeutic interventions.22, 23, 24 Meanwhile, E-cadherin, Vimentin, and Snail proteins serve as EMT markers for EMT induction.23 This evidence concerns the gene SNAI1 and cancer.